Avid Bioservices Inc (NASDAQ: CDMO) Now -1.44% Off Its High ($12.48), Does Analysts See Headwinds And Risks?

Avid Bioservices Inc (NASDAQ:CDMO) currently has a daily average trading volume of 1.88M but it saw 1481006 shares traded in last market. With a market cap of 786.75M USD, the company’s current market price of $12.30 came falling about -0.49 while comparing to the previous closing price of $12.36. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.48 and as low as $5.65. In the recent trading on the day, stock has struck highest price mark of $12.28 while lowest mark touched by it was $12.38.

Taking a look at 20-day trading activity of Avid Bioservices Inc (CDMO) gives us an average price of $12.30, while its current price level is -1.44% below from 52-week high level whereas it is 117.70% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $11.42 while that of 200 days or SMA-200 reads an average of $9.37. A closer look into the stock’s movement over the week reveals that its volatility is standing at 0.63% during that period while stretching the period over a month that increases to 0.76%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 63.04 which implies that the stock is in neutral territory.

KeyBanc Capital Markets upgraded its recommendation for the stock as a “Overweight” from “Sector Weight” on March 14, 2023 while assigning a price target of $20.

Over the week, CDMO’s stock price is moving 0.57% up while it is 1.15% when we observe its performance for the past one month. Year-to-date it is 89.23% up and over the past year, the stock is showing an upside performance of 101.31%.

Currently, Avid Bioservices Inc’s total number of outstanding shares is 63.96M. Company’s return on investment (ROI) stands at -61.09% and return on equity (ROE) at -133.29%. Stock’s beta reads 1.41. Stock has a price to book (P/B) ratio of 17.56 while price to sale or P/S ratio amounts to 5.23. Its return on asset (ROA) is -39.04% on average.